Trial intelligence / Profile preview

Effect of dexmedetomidine on oxygenation in thoracotomy with double-lung ventilation

IRCT201610174731N15Phase 3Completed

Sponsor
Tabriz University of Medical Sciences
Start
Aug 2016
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of dexmedetomidine in Ventilation disorder of lung, sponsored by Tabriz University of Medical Sciences. Primary endpoint: Oxygenation parameters. Started Aug 2016; status: completed.

02

Drugs

dexmedetomidine
03

Conditions

Ventilation disorder of lung

Beyond the preview

Go deeper on IRCT201610174731N15.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT201610174731N15.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call